CIK
2023-01-06
//@daz888888:

$Lucira Health, Inc.(LHDX)$ 

Lucira Health, Inc.

LHDX

+434.6%

+ Free Alerts

shares are surging higher on Tuesday after the company announced it submitted an Emergency Use Authorization application to the FDA for over-the-counter use of its COVID-19 & Flu test.

What happened: Today, Lucira announced that it submitted an Emergency Use Authorization (EUA) application for its at-home molecular COVID-19 & Flu test kits. The company first received EUA for point-of-care use in a healthcare setting in November 2022.

The company’s kits test for COVID-19 and influenza, which the company noted, have similar symptoms but different treatments that are most effective early in an infection. The test aims to differentiate between the two viruses quickly.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
47